October 30 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said that its net proft fell by an annual 30.4% to 27.7 million levs ($16.1 million/14.2 million euro) in the first nine months of the year, as the company's sales declined, including an 11% drop in sales in Russia.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
